Hypopigmented Junctional BAP1‐Inactivated Melanocytoma: A Paradigm Shift
- 6 April 2025
- journal article
- case report
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 52 (6) , 428-431
Abstract
Since their original description by Wiesner et al., the spectrum of clinical, histopathologic, and molecular findings of BAP1 (BRCA1‐associated protein 1)‐inactivated melanocytomas has been more fully characterized. Herein, we report an exceptional presentation of multiple junctional melanocytic BAP1‐inactivated melanocytomas with a clinically hypopigmented appearance in a patient. Targeted DNA sequencing demonstrated the same BAP1 frameshift mutation (BAP1 p.R59f) in three different lesions. One of the specimens also displayed two truncating mutations in NF1 (NF1 p.Q129* and NF1 p.Q1801*) at 8%–9% mutant allele frequency. To our knowledge, BIM confined entirely to the epidermis, and multiple BIMs presenting in hypopigmented fashion have not been widely reported previously.Keywords
This publication has 13 references indexed in Scilit:
- Beyond typical histology of BAP1-inactivated melanocytomaPathology - Research and Practice, 2024
- Histopathologic and molecular characterization of BAP‐1‐inactivated melanomaJournal of Cutaneous Pathology, 2022
- BRCA1‐associated protein (BAP1)‐inactivated melanocytic tumorsJournal of Cutaneous Pathology, 2019
- Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy SocietyJournal of the American Academy of Dermatology, 2019
- Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumorsJournal of the American Academy of Dermatology, 2018
- The Genetic Evolution of Melanoma from Precursor LesionsNew England Journal of Medicine, 2015
- BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferationsHuman Pathology, 2015
- Tumours associated with BAP1 mutationsPathology, 2013
- A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 ExpressionAmerican Journal of Surgical Pathology, 2012
- Germline mutations in BAP1 predispose to melanocytic tumorsNature Genetics, 2011